Glioblastoma, also known as glioblastoma multiforme (GBM), is the most common primary brain tumor. Extensive research has been carried out to discover the factors associated with the course and progression of GBM. CD133 is a glycoprotein antigen found in normal and malignant tissues. CD133 has been recognized as a marker for the growth of cancer cells. The association between this tissue marker and GBM is being investigated. The aim of this review was to evaluate the role of CD133 as a tumor marker for the prognosis of GBM
(2018). CD133 expression in glioblastoma multiforme: A literature review. Cureus, 10(10), 3439-3443.
Available at: https://ecommons.aku.edu/pakistan_fhs_mc_surg_neurosurg/170
Creative Commons License
This work is licensed under a Creative Commons Attribution-Noncommercial 4.0 License